---
title: "BTBP: Recently officially launched Phase III clinical trials for human prothrombin complex"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/262017471.md"
description: "BTBP announced that its subsidiary has officially launched the Phase III clinical trial of human prothrombin complex, which is used to treat various coagulation factor deficiencies. Although similar products are already available in domestic and international markets, this product still needs to complete clinical trials and market application, and investors should be aware of the associated risks"
datetime: "2025-10-21T09:34:25.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/262017471.md)
  - [en](https://longbridge.com/en/news/262017471.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/262017471.md)
---

# BTBP: Recently officially launched Phase III clinical trials for human prothrombin complex

BTBP announced that its subsidiary, China National Pharmaceutical Group Wuhan Biological Products Co., Ltd., has completed the clinical ethical review and preparations for clinical enrollment for the human prothrombin complex it developed, and has officially launched Phase III clinical trials recently. This product is mainly used for the treatment of congenital and acquired deficiencies of coagulation factors II, VII, IX, and X, including Hemophilia B, anticoagulant overdose, and vitamin K deficiency. Currently, several companies in the domestic market produce this product, and there are also several multinational companies producing it in the international market. However, this product still needs to complete Phase III clinical trials and submit a drug marketing authorization application, among other procedures, and there are many internal and external uncertainties. Investors are advised to pay attention to investment risks

### Related Stocks

- [600161.CN](https://longbridge.com/en/quote/600161.CN.md)

## Related News & Research

- [ZAWYA: Kia’s global partner, The Ocean Cleanup expands plastic interception project ahead of LA28](https://longbridge.com/en/news/287182378.md)
- [METALS-Copper ticks higher on Chile supply worries and hopes for Iran war deal](https://longbridge.com/en/news/287043513.md)
- [China's Bio-Thera Gets US Nod for Golimumab Biosimilar](https://longbridge.com/en/news/286880573.md)
- [09:15 ETNewport Healthcare's 2025 Outcomes Report Demonstrates Significant Improvements in Teen and Young Adult Mental Health Following Treatment](https://longbridge.com/en/news/286920260.md)
- [08:47 ETVIN Foundation Opens Free CE Courses Aimed at Providing Clinical Confidence to New Veterinary Graduates](https://longbridge.com/en/news/286915474.md)